Latest filing published 12 Jul 2013 for LIVE VENTURES Inc, €2,233.
No signal scores available.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Greg A. Leclaire across 4 companies, led by Clearone Inc, LIVE VENTURES Inc and Utah Medical Products Inc. In total, 73 filings cover trades dated from 3 January 2006 to 1 July 2013.
The open-market record is one-sided, with 12 purchases worth €43k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 25 share grants and 7 option exercises.
Half of the purchases are above €2,152 and half below. After 6 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +5.1%. This is a record of the past, not a forecast.
Most recently, on 12 July 2013, the filings show a share grant worth €2,233 in LIVE VENTURES Inc. The last insider purchase was made public on 30 December 2010, 5,777 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 64 declarations